106 related articles for article (PubMed ID: 20453879)
1. An oncogenic role of eIF3e/INT6 in human breast cancer.
Grzmil M; Rzymski T; Milani M; Harris AL; Capper RG; Saunders NJ; Salhan A; Ragoussis J; Norbury CJ
Oncogene; 2010 Jul; 29(28):4080-9. PubMed ID: 20453879
[TBL] [Abstract][Full Text] [Related]
2. Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells.
Gillis LD; Lewis SM
Oncogene; 2013 Aug; 32(31):3598-605. PubMed ID: 22907435
[TBL] [Abstract][Full Text] [Related]
3. Arabidopsis eIF3e is regulated by the COP9 signalosome and has an impact on development and protein translation.
Yahalom A; Kim TH; Roy B; Singer R; von Arnim AG; Chamovitz DA
Plant J; 2008 Jan; 53(2):300-11. PubMed ID: 18067529
[TBL] [Abstract][Full Text] [Related]
4. The Bad, the Good and eIF3e/INT6.
Sesen J; Casaos J; Scotland SJ; Seva C; Eisinger-Mathason TS; Skuli N
Front Biosci (Landmark Ed); 2017 Jan; 22(1):1-20. PubMed ID: 27814599
[TBL] [Abstract][Full Text] [Related]
5. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
[TBL] [Abstract][Full Text] [Related]
6. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
Luparello C; Sirchia R; Pupello D
J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
[TBL] [Abstract][Full Text] [Related]
7. Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling Pathway.
Desnoyers G; Frost LD; Courteau L; Wall ML; Lewis SM
Mol Cancer Res; 2015 Oct; 13(10):1421-30. PubMed ID: 26056130
[TBL] [Abstract][Full Text] [Related]
8. INT6/eIF3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells.
Gotoh-Saito S; Sadato D; Shibasaki F
Genes Cells; 2022 Dec; 27(12):689-705. PubMed ID: 36116043
[TBL] [Abstract][Full Text] [Related]
9. Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.
Sesen J; Cammas A; Scotland SJ; Elefterion B; Lemarié A; Millevoi S; Mathew LK; Seva C; Toulas C; Moyal EC; Skuli N
Int J Mol Sci; 2014 Jan; 15(2):2172-90. PubMed ID: 24481065
[TBL] [Abstract][Full Text] [Related]
10. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth.
Dong Z; Liu LH; Han B; Pincheira R; Zhang JT
Oncogene; 2004 May; 23(21):3790-801. PubMed ID: 15094776
[TBL] [Abstract][Full Text] [Related]
11. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.
Dong Z; Zhang JT
Crit Rev Oncol Hematol; 2006 Sep; 59(3):169-80. PubMed ID: 16829125
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts.
Watkins SJ; Norbury CJ
Cell Prolif; 2004 Apr; 37(2):149-60. PubMed ID: 15030549
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.
Sadato D; Ono T; Gotoh-Saito S; Kajiwara N; Nomura N; Ukaji M; Yang L; Sakimura K; Tajima Y; Oboki K; Shibasaki F
FEBS Open Bio; 2018 Aug; 8(8):1188-1201. PubMed ID: 30087825
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
18. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
